Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2005-11-02 (20 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT-PAUL (97460), La Reunion
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE SAINT-GILLES-LES-BAINS : revenue, balance sheet and financial ratios
PHARMACIE DE SAINT-GILLES-LES-BAINS is a French company
founded 20 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-PAUL (97460),
this company of category PME
shows in 2025 a net income positive of 116 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE SAINT-GILLES-LES-BAINS (SIREN 484600051)
Indicator
2025
2024
2023
2021
2020
2019
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
Net income
115 780 €
108 442 €
29 754 €
104 711 €
81 168 €
131 031 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
Im Jahr 2025 erzielt PHARMACIE DE SAINT-GILLES-LES-BAINS ein positives Nettoergebnis von 116 k€. Entwicklung 2019-2025: 131 k€ -> 116 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
115 780 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
Die Verschuldungsquote (= Finanzschulden / Eigenkapital x 100) beträgt 3%. Dieses niedrige Niveau spiegelt eine solide Finanzstruktur wider. Die finanzielle Autonomie (= Eigenkapital / Bilanzsumme x 100) erreicht 78%. Diese hohe Autonomie bedeutet, dass das Unternehmen den Großteil seiner Vermögenswerte durch Eigenkapital finanziert.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
2.824%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
77.712%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE SAINT-GILLES-LES-BAINS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2023
2024
2025
Debt ratio
27.458
27.421
19.985
7.796
4.384
2.824
Financial autonomy
65.182
63.528
65.896
72.763
74.19
77.712
Repayment capacity
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
Sector positioning
Verschuldungsgrad
2.822025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Ausgezeichnet
Im Jahr 2025 liegt in den unteren 25% der Branche, was positiv ist das verschuldungsgrad von PHARMACIE DE SAINT-GILLES... (2.82). Dieses Verhältnis misst das Gewicht der Schulden im Verhältnis zum Eigenkapital. Ein niedriges Verhältnis zeigt eine solide Finanzstruktur mit geringer Abhängigkeit von Gläubigern.
Finanzielle Autonomie
77.71%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Ausgezeichnet
Im Jahr 2025 liegt in den oberen 25% der Branche das finanzielle autonomie von PHARMACIE DE SAINT-GILLES... (77.7%). Dieses Verhältnis stellt den Anteil des Eigenkapitals an der Gesamtfinanzierung dar. Hohe Autonomie spiegelt finanzielle Unabhängigkeit und Fähigkeit wider, Schocks zu absorbieren.
Liquidity ratios
Die Liquiditätsquote beträgt 118.79. Das Unternehmen verfügt über 2€ liquide Mittel für jeden 1€ kurzfristiger Schulden.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
118.791
Liquidity indicators evolution PHARMACIE DE SAINT-GILLES-LES-BAINS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2023
2024
2025
Liquidity ratio
99.098
118.288
113.548
81.864
101.152
118.791
Interest coverage
None
None
None
None
None
None
Sector positioning
Liquiditätsquote
118.792025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Beobachten+7 pts over 3 years
Im Jahr 2025 liegt in den unteren 25% der Branche das liquiditätsquote von PHARMACIE DE SAINT-GILLES... (118.79). Dieses Verhältnis misst die Fähigkeit, kurzfristige Schulden mit Umlaufvermögen zu decken. Ein Verhältnis unter 1 kann auf potenzielle Liquiditätsspannungen hinweisen.
Positioning of PHARMACIE DE SAINT-GILLES-LES-BAINS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE SAINT-GILLES-LES-BAINS is estimated at
1 839 179 €
(range 1 248 075€ - 2 885 925€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1248k€1839k€2885k€
1 839 179 €Range: 1 248 075€ - 2 885 925€
NAF 5 année 2025
Valuation method used
Net Income Multiple
115 780 €
×
15.9x
=1 839 179 €
Range: 1 248 076€ - 2 885 925€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE SAINT-GILLES-LES-BAINS with other companies in the same sector:
Frequently asked questions about PHARMACIE DE SAINT-GILLES-LES-BAINS
What is the revenue of PHARMACIE DE SAINT-GILLES-LES-BAINS ?
The revenue of PHARMACIE DE SAINT-GILLES-LES-BAINS is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE SAINT-GILLES-LES-BAINS profitable?
Yes, PHARMACIE DE SAINT-GILLES-LES-BAINS generated a net profit of 116 k€ in 2025.
Where is the headquarters of PHARMACIE DE SAINT-GILLES-LES-BAINS ?
The headquarters of PHARMACIE DE SAINT-GILLES-LES-BAINS is located in SAINT-PAUL (97460), in the department La Reunion.
Where to find the tax return of PHARMACIE DE SAINT-GILLES-LES-BAINS ?
The tax return of PHARMACIE DE SAINT-GILLES-LES-BAINS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE SAINT-GILLES-LES-BAINS operate?
PHARMACIE DE SAINT-GILLES-LES-BAINS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart